Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Somatostatin receptor type 5 is a critical GPCR involved in hormonal regulation across multiple tissues. Its structure-function relationships are well-characterized at high resolution, making it an attractive therapeutic target—especially for conditions involving excess hormone production such as acromegaly or certain neuroendocrine tumors. Genetic variation can modulate its physiological impact or disease associations.
Agonist binding to SSTR5 induces conformational changes, leading to Gαi protein engagement, inhibition of adenylyl cyclase, and reduced cAMP levels.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Somatostatin Receptor Type 5.